Dec 15 (Reuters) - Australian Clinical Labs Ltd (ACL) :
- INTENTION TO WITHDRAW TAKEOVER OFFER FOR HEALIUS
- NO LONGER BELIEVES OFFER CONSIDERATION OF 0.74 ACL SHARES FOR EACH HEALIUS SHARE FAIRLY REFLECTS RELATIVE CONTRIBUTION
- ACL BOARD IS CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS IS AT RISK OF A SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
- CONTINUES TO BELIEVE BENEFITS OF A MERGER BETWEEN ACL AND HEALIUS ARE COMPELLING
- ALSO NOTES THAT ACCC TODAY ANNOUNCED THAT IT OPPOSES COMBINATION OF ACL AND HEALIUS
- REMAINS OPEN TO A MERGER BETWEEN CO & HEALIUS
- ACL BOARD INTENDS TO CLOSELY MONITOR PERFORMANCE OF HEALIUS IN COMING MONTHS & REMAINS OPEN TO MERGER BETWEEN 2 COMPANIES
- CONCERNED BASED ON 1H GUIDANCE THAT HEALIUS IS AT RISK OF A SIGNIFICANT STATUTORY NPAT LOSS IN 1H FY24
- DECISION BY ACCC GIVES CO ABILITY TO CHALLENGE ACCC'S POSITION DIRECTLY IN COURT IF IT MAKES A NEW OFFER IN NEAR FUTURE
Dec 15 (Reuters) - Australian Clinical Labs Ltd (ACL) :...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.83 |
Change
-0.040(1.39%) |
Mkt cap ! $555.7M | |||
| Open | High | Low | Value | Volume |
| $2.87 | $2.89 | $2.83 | $1.569M | 550.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 23208 | $2.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.85 | 11000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| ACL (ASX) Chart |